{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:30:17Z","timestamp":1787729417931,"version":"build-2784847793"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T00:00:00Z","timestamp":1467158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/npp.2016.108","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T08:21:27Z","timestamp":1467188487000},"page":"2994-3002","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users"],"prefix":"10.1038","volume":"41","author":[{"given":"Isabelle","family":"Boileau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9313-2587","authenticated-orcid":false,"given":"Doris","family":"Payer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo M","family":"Rusjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Houle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"McCluskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan A","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,29]]},"reference":[{"key":"BFnpp2016108_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2014.03.023","volume":"732","author":"MG Baladi","year":"2014","unstructured":"Baladi MG, Newman AH, Nielsen SM, Hanson GR, Fleckenstein AE (2014). Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia. Eur J Pharmacol 732: 105\u2013110.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2016108_CR2","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1093\/brain\/awn337","volume":"132","author":"I Boileau","year":"2009","unstructured":"Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J et al (2009). Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain 132: 1366\u20131375.","journal-title":"Brain"},{"key":"BFnpp2016108_CR3","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/npp.2015.267","volume":"41","author":"I Boileau","year":"2015","unstructured":"Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ (2015a). Rapid recovery of vesicular dopamine levels in methamphetamine users in early abstinence. Neuropsychopharmacology 41: 1179\u20131187.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016108_CR4","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.euroneuro.2015.06.002","volume":"25","author":"I Boileau","year":"2015","unstructured":"Boileau I, Nakajima S, Payer D (2015b). Imaging the D3 dopamine receptor across behavioral and drug addictions: positron emission tomography studies with [(11)C]-(+)-PHNO. Eur Neuropsychopharmacol 25: 1410\u20131420.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2016108_CR5","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/mp.2013.163","volume":"19","author":"I Boileau","year":"2014","unstructured":"Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA et al (2014). In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [C]-(+)-PHNO. Mol Psychiatry 19: 1305\u20131313.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016108_CR6","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1523\/JNEUROSCI.4371-11.2012","volume":"32","author":"I Boileau","year":"2012","unstructured":"Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J et al (2012). Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci 32: 1353\u20131359.","journal-title":"J Neurosci"},{"key":"BFnpp2016108_CR7","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/npp.2014.30","volume":"39","author":"ES Calipari","year":"2014","unstructured":"Calipari ES, Sun H, Eldeeb K, Luessen DJ, Feng X, Howlett AC et al (2014). Amphetamine self-administration attenuates dopamine D2 autoreceptor function. Neuropsychopharmacology 39: 1833\u20131842.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016108_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.nbd.2014.12.007","volume":"74","author":"J Castro-Hernandez","year":"2015","unstructured":"Castro-Hernandez J, Afonso-Oramas D, Cruz-Muros I, Salas-Hernandez J, Barroso-Chinea P, Moratalla R et al (2015). Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake. Neurobiol Dis 74: 325\u2013335.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2016108_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","volume":"49","author":"WC Drevets","year":"2001","unstructured":"Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al (2001). Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 49: 81.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2016108_CR10","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/npp.2014.18","volume":"39","author":"D Erritzoe","year":"2014","unstructured":"Erritzoe D, Tziortzi A, Bargiela D, Colasanti A, Searle GE, Gunn RN et al (2014). In vivo imaging of cerebral dopamine D3 receptors in alcoholism. Neuropsychopharmacology 39: 1703\u20131712.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016108_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","volume":"90","author":"M Gossop","year":"1995","unstructured":"Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W et al (1995). The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90: 607\u2013614.","journal-title":"Addiction"},{"key":"BFnpp2016108_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35075076","volume":"411","author":"O Guillin","year":"2001","unstructured":"Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P (2001). BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411: 86\u201389.","journal-title":"Nature"},{"key":"BFnpp2016108_CR13","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1523\/JNEUROSCI.20-06-02369.2000","volume":"20","author":"SN Haber","year":"2000","unstructured":"Haber SN, Fudge JL, McFarland NR (2000). Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20: 2369.","journal-title":"J Neurosci"},{"key":"BFnpp2016108_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1749-6632.2009.05149.x","volume":"1187","author":"CA Heidbreder","year":"2010","unstructured":"Heidbreder CA, Newman AH (2010). Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders. Ann NY Acad Sci 1187: 4\u201334.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp2016108_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00702-007-0017-0","volume":"115","author":"J Ji","year":"2008","unstructured":"Ji J, Dluzen DE (2008). Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. J Neural Transm 115: 809\u2013817.","journal-title":"J Neural Transm"},{"key":"BFnpp2016108_CR16","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","volume":"18","author":"SR Jones","year":"1998","unstructured":"Jones SR, Gainetdinov RR, Wightman RM, Caron MG (1998). Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18: 1979.","journal-title":"J Neurosci"},{"key":"BFnpp2016108_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1741-7007-2-22","volume":"2","author":"JN Joyce","year":"2004","unstructured":"Joyce JN, Woolsey C, Ryoo H, Borwege S, Hagner D (2004). Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor. BMC Biol 2: 22.","journal-title":"BMC Biol"},{"key":"BFnpp2016108_CR18","doi-asserted-by":"publisher","first-page":"S717","DOI":"10.1016\/S1053-8119(18)31550-7","volume":"7","author":"NJ Kabani","year":"1998","unstructured":"Kabani NJ, MacDonald D, Holmes CJ, Evans AC (1998). 3D anatomical atlas of the human brain. Neuroimage 7: S717.","journal-title":"Neuroimage"},{"key":"BFnpp2016108_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/B978-0-12-418679-8.00008-3","volume-title":"The Effects of Drug Abuse on the Human Nervous System","author":"SJ Kish","year":"2014","unstructured":"Kish SJ . Chapter 08: The pathology of methamphetamine use in the human brain. In: Madras B, Kuhar M (eds). The Effects of Drug Abuse on the Human Nervous System. Elsevier Inc: Oxford, UK; (2014, pp 203\u2013298."},{"key":"BFnpp2016108_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP (1996). Simplified reference tissue model for PET receptor studies. Neuroimage 4: 153.","journal-title":"Neuroimage"},{"key":"BFnpp2016108_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-444-63425-2.00011-8","volume":"211","author":"B Le Foll","year":"2014","unstructured":"Le Foll B, Collo G, Rabiner EA, Boileau I, Merlo Pich E, Sokoloff P (2014). Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings. Progr Brain Res 211: 255\u2013275.","journal-title":"Progr Brain Res"},{"key":"BFnpp2016108_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/00001756-200502080-00022","volume":"16","author":"B Le Foll","year":"2005","unstructured":"Le Foll B, Diaz J, Sokoloff P (2005). A single cocaine exposure increases BDNF and D3 receptor expressions:implications for drug-conditioning. Neuroreport 16: 175\u2013178.","journal-title":"Neuroreport"},{"key":"BFnpp2016108_CR23","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1073\/pnas.92.5.1719","volume":"92","author":"D Levesque","year":"1995","unstructured":"Levesque D, Martres MP, Diaz J, Griffon N, Lammers CH, Sokoloff P et al (1995). A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc Natl Acad Sci USA 92: 1719\u20131723.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2016108_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1176\/appi.ajp.2010.10050748","volume":"168","author":"D Martinez","year":"2011","unstructured":"Martinez D, Carpenter KM, Liu F, Slifstein M, Broft A, Friedman AC et al (2011). Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. Am J Psychiatry 168: 634\u2013641.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016108_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1176\/appi.ajp.2009.08121801","volume":"166","author":"D Martinez","year":"2009","unstructured":"Martinez D, Greene K, Broft A, Kumar D, Liu F, Narendran R et al (2009). Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)\/D(3) receptors following acute dopamine depletion. Am J Psychiatry 166: 1170\u20131177.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016108_CR26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al (2003). Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2016108_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.mp.4000230","volume":"2","author":"DC Mash","year":"1997","unstructured":"Mash DC (1997). D3 receptor binding in human brain during cocaine overdose. Mol Psychiatry 2: 5\u20136.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016108_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.drugalcdep.2014.03.013","volume":"139","author":"D Matuskey","year":"2014","unstructured":"Matuskey D, Gallezot JD, Pittman B, Williams W, Wanyiri J, Gaiser E et al (2014). Dopamine D(3) receptor alterations in cocaine-dependent humans imaged with [(1)(1)C](+)PHNO. Drug Alcohol Depend 139: 100\u2013105.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2016108_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1176\/appi.ajp.2011.11010126","volume":"169","author":"R Narendran","year":"2012","unstructured":"Narendran R, Lopresti BJ, Martinez D, Mason NS, Himes M, May MA et al (2012). In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers. Am J Psychiatry 169: 55\u201363.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016108_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/syn.20566","volume":"62","author":"R Narendran","year":"2008","unstructured":"Narendran R, Martinez D (2008). Cocaine abuse and sensitization of striatal dopamine transmission: a critical review of the preclinical and clinical imaging literature. Synapse 62: 851\u2013869.","journal-title":"Synapse"},{"key":"BFnpp2016108_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1176\/appi.ajp.2014.13121581","volume":"171","author":"R Narendran","year":"2014","unstructured":"Narendran R, Mason NS, Paris J, Himes ML, Douaihy AB, Frankle WG (2014). Decreased prefrontal cortical dopamine transmission in alcoholism. Am J Psychiatry 171: 881\u2013888.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2016108_CR32","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/sj.npp.1300456","volume":"29","author":"JL Neisewander","year":"2004","unstructured":"Neisewander JL, Fuchs RA, Tran-Nguyen LT, Weber SM, Coffey GP, Joyce JN (2004). Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 29: 1479\u20131487.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016108_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/npp.2013.192","volume":"39","author":"DE Payer","year":"2014","unstructured":"Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM et al (2014). Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [C]-(+)-PHNO. Neuropsychopharmacology 39: 311\u2013318.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016108_CR34","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/sj.npp.1301163","volume":"31","author":"NM Richtand","year":"2006","unstructured":"Richtand NM (2006). Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function. Neuropsychopharmacology 31: 2368\u20132375.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016108_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1360-0443.2001.9611038.x","volume":"96","author":"TE Robinson","year":"2001","unstructured":"Robinson TE, Berridge KC (2001). Incentive-sensitization and addiction. Addiction 96: 103.","journal-title":"Addiction"},{"key":"BFnpp2016108_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pscychresns.2006.01.011","volume":"147","author":"P Rusjan","year":"2006","unstructured":"Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F et al (2006). An automated method for the extraction of regional data from PET images. Psychiatry Res 147: 79\u201389.","journal-title":"Psychiatry Res"},{"key":"BFnpp2016108_CR37","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/npp.2014.301","volume":"40","author":"A Schrantee","year":"2015","unstructured":"Schrantee A, Vaclavu L, Heijtel DF, Caan MW, Gsell W, Lucassen PJ et al (2015). Dopaminergic system dysfunction in recreational dexamphetamine users. Neuropsychopharmacology 40: 1172\u20131180.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2016108_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/syn.20987","volume":"66","author":"P Seeman","year":"2012","unstructured":"Seeman P (2012). Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans. Synapse 66: 88\u201393.","journal-title":"Synapse"},{"key":"BFnpp2016108_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","volume":"32","author":"P Shotbolt","year":"2012","unstructured":"Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S et al (2012a). Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J Cereb Blood Flow Metab 32: 127\u2013136.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2016108_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","volume":"32","author":"P Shotbolt","year":"2012","unstructured":"Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S et al (2012b). Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J Cereb Blood Flow Metab 32: 127\u2013136.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2016108_CR41","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1523\/JNEUROSCI.4050-13.2014","volume":"34","author":"CA Siciliano","year":"2014","unstructured":"Siciliano CA, Calipari ES, Ferris MJ, Jones SR (2014). Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci 34: 5575\u20135582.","journal-title":"J Neurosci"},{"key":"BFnpp2016108_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bcp.2011.09.008","volume":"83","author":"M Skinbjerg","year":"2012","unstructured":"Skinbjerg M, Sibley DR, Javitch JA, Abi-Dargham A (2012). Imaging the high-affinity state of the dopamine D2 receptor in vivo: fact or fiction? Biochem Pharmacol 83: 193\u2013198.","journal-title":"Biochem Pharmacol"},{"key":"BFnpp2016108_CR43","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1523\/JNEUROSCI.16-19-06100.1996","volume":"16","author":"JK Staley","year":"1996","unstructured":"Staley JK, Mash DC (1996). Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 16: 6100\u20136106.","journal-title":"J Neurosci"},{"key":"BFnpp2016108_CR44","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.neuropharm.2013.06.031","volume":"76 Pt B","author":"P Trifilieff","year":"2014","unstructured":"Trifilieff P, Martinez D (2014). Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity. Neuropharmacology 76 Pt B: 498\u2013509.","journal-title":"Neuropharmacology"},{"key":"BFnpp2016108_CR45","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi AC, Searle GE, Tzimopoulou S, Salinas C, Beaver JD, Jenkinson M et al (2011). Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 54: 264\u2013277.","journal-title":"Neuroimage"},{"key":"BFnpp2016108_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00210-012-0817-0","volume":"386","author":"JP van Wieringen","year":"2013","unstructured":"van Wieringen JP, Booij J, Shalgunov V, Elsinga P, Michel MC (2013). Agonist high- and low-affinity states of dopamine D(2) receptors: methods of detection and clinical implications. Naunyn Schmiedebergs Arch Pharmacol 386: 135\u2013154.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFnpp2016108_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neuroimage.2015.07.035","volume":"121","author":"ND Volkow","year":"2015","unstructured":"Volkow ND, Wang GJ, Smith L, Fowler JS, Telang F, Logan J et al (2015). Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release. Neuroimage 121: 20\u201328.","journal-title":"Neuroimage"},{"key":"BFnpp2016108_CR48","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/mp.2011.86","volume":"17","author":"GJ Wang","year":"2012","unstructured":"Wang GJ, Smith L, Volkow N, Telang F, Logan J, Tomasi D et al (2012). Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry 17: 918\u2013925.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2016108_CR49","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/nm0696-699","volume":"2","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM et al (1996a). Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 2: 699\u2013703.","journal-title":"Nat Med"},{"key":"BFnpp2016108_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ana.410400312","volume":"40","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F et al (1996b). Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 40: 428\u2013439.","journal-title":"Ann Neurol"},{"key":"BFnpp2016108_CR51","doi-asserted-by":"publisher","first-page":"35842","DOI":"10.1074\/jbc.M611758200","volume":"282","author":"A Zapata","year":"2007","unstructured":"Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D et al (2007). Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. J Biol Chem 282: 35842\u201335854.","journal-title":"J Biol Chem"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2016108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2016108","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2016108.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:54:54Z","timestamp":1684439694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2016108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,29]]},"references-count":51,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFnpp2016108"],"URL":"https:\/\/doi.org\/10.1038\/npp.2016.108","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726470863.793520576","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,29]]},"assertion":[{"value":"18 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}